Skip to main content
Viruses logoLink to Viruses
. 2024 Mar 4;16(3):397. doi: 10.3390/v16030397

Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429

Sarah Cook 1,*, Luke Wittenburg 2, Victoria C Yan 3, Jacob H Theil 4, Diego Castillo 1, Krystle L Reagan 5, Sonyia Williams 1, Cong-Dat Pham 3, Chun Li 3, Florian L Muller 6, Brian G Murphy 1
PMCID: PMC10975337  PMID: 38543851

Error in Table

In the original publication [1], incorrect numerical data were entered into the last three numbers in the AUC column of Table 5 and this mistake was not recognized by our review team. This error was identified by Sally Coggins who brought it to our attention. Corrected Table 5 appears below.

Table 5.

Pharmacokinetic parameters for GS-441524 after a single IV dose of RDV (7 mg/kg) in 3 cats.

Cat ID Cmax
(ng/mL; μM)
Tmax
(h)
T1/2
(h)
AUC
(h*ng/mL)
20-045 1730 (5.94) 0.5 5.3 14,271
21-001 1960 (6.73) 1 5.7 15,291
21-004 2320 (7.97) 1 4.5 9924
Mean 2003 (6.88) 0.83 5.2 13,162
SD 297 (1.0) 0.29 0.6 2850

Text Correction

With regard to the correction of Table 5, a correction has been made to Section 3.4, Paragraph 3.

“Finally, in the IV RDV cohort, GS-441524 exhibited an average plasma Cmax of 2003 ng/mL (6.9 μM) at a corresponding Tmax of 0.83 h and an average AUC0-24 value of 13,162 h*ng/mL (45 μM*h; average C24 = 64 ± 32 ng/mL, 0.22 ± 0.11 μM) (Table 5).”

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Cook S., Wittenburg L., Yan V.C., Theil J.H., Castillo D., Reagan K., Williams S., Pham C.-D., Li C., Muller F.L., et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses. 2022;14:2429. doi: 10.3390/v14112429. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Viruses are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES